The Prevalence of Osteoporosis in Rheumatoid Arthritis Patient: a Systematic Review and Meta-analysis

Overview

Journal Sci Rep

Specialty Science

Date 2022 Sep 23

PMID 36151246

Authors

Samaneh Moshayedi

Baharak Tasorian

Amir Almasi-Hashiani

Affiliations

Soon will be listed here.

Abstract

Osteoporosis (OP) is one of the most commonly known extra-articular complications of rheumatoid arthritis (RA). Since the prevalence of OP is diverse in different studies and there is no general consensus about it, in this systematic review, we aimed to investigate the global prevalence of OP among RA patients. In this review, three databases including Medline via PubMed, Scopus, and Web of Science (Clarivate analytics) were searched by various keywords. After screening of retrieved papers, the related data of included papers were extracted and analyzed. To assess the risk of methodological bias of included studies, quality assessment checklist for prevalence studies was used. Because of heterogeneity among studies, random-effect model was used to pooled the results of primary studies. In this review, the results of 57 studies were summarized and the total included sample size was 227,812 cases of RA with 64,290 cases of OP. The summary point prevalence of OP among RA was estimated as 27.6% (95%CI 23.9-31.3%). Despite significant advances in prevention, treatment and diagnostic methods in these patients, it still seems that the prevalence of OP in these patients is high and requires better and more timely interventions.

Citing Articles

Rheumatoid arthritis and the risk of fracture: A Mendelian randomization study.

Zhang Y, Weng Q, Deng Z, Zhang H, Dai J, Chen X Medicine (Baltimore). 2025; 104(3):e41248.

PMID: 39833078 PMC: 11749589. DOI: 10.1097/MD.0000000000041248.

Targeting TRPC channels for control of arthritis-induced bone erosion.

Ray S, McCall J, Tian J, Jeon J, Douglas A, Tyler K Sci Adv. 2025; 11(3):eabm9843.

PMID: 39813349 PMC: 11734723. DOI: 10.1126/sciadv.abm9843.

Chinese guidelines for the diagnosis and treatment of rheumatoid arthritis: 2024 update.

Tian X, Wang Q, Jiang N, Zhao Y, Huang C, Liu Y Rheumatol Immunol Res. 2025; 5(4):189-208.

PMID: 39802551 PMC: 11720473. DOI: 10.1515/rir-2024-0028.

Zrour S, Belhaj Salem S, Ben Chekaya N, Grassa R, Bejia I, Abid A Tunis Med. 2025; 102(12):1078-1083.

PMID: 39748698 PMC: 11770796. DOI: 10.62438/tunismed.v102i12.5178.

Fractal analysis of jawbone structure in patients with rheumatoid arthritis.

Celebi E, Gormez O, Dogru A, Aydogan T, Orhan H Imaging Sci Dent. 2025; 54(4):345-353.

PMID: 39744549 PMC: 11685309. DOI: 10.5624/isd.20240065.

References

Hu Z, Zhang L, Lin Z, Zhao C, Xu S, Lin H . Prevalence and risk factors for bone loss in rheumatoid arthritis patients from South China: modeled by three methods. BMC Musculoskelet Disord. 2021; 22(1):534. PMC: 8199806. DOI: 10.1186/s12891-021-04403-5. View

Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. PMC: 8005924. DOI: 10.1136/bmj.n71. View

Jin S, Li M, Wang Q, Zeng X, Xia W, Yu W . Bone mineral density and microarchitecture among Chinese patients with rheumatoid arthritis: a cross-sectional study with HRpQCT. Arthritis Res Ther. 2021; 23(1):127. PMC: 8067377. DOI: 10.1186/s13075-021-02503-0. View

Vis M, Haavardsholm E, Boyesen P, Haugeberg G, Uhlig T, Hoff M . High incidence of vertebral and non-vertebral fractures in the OSTRA cohort study: a 5-year follow-up study in postmenopausal women with rheumatoid arthritis. Osteoporos Int. 2011; 22(9):2413-9. PMC: 3150654. DOI: 10.1007/s00198-010-1517-6. View

Nyhall-Wahlin B, Ajeganova S, Petersson I, Andersson M . Increased risk of osteoporotic fractures in Swedish patients with rheumatoid arthritis despite early treatment with potent disease-modifying anti-rheumatic drugs: a prospective general population-matched cohort study. Scand J Rheumatol. 2019; 48(6):431-438. DOI: 10.1080/03009742.2019.1611918. View

Lee J, Sung Y, Choi C, Cho S, Bang S, Choe J . The frequency of and risk factors for osteoporosis in Korean patients with rheumatoid arthritis. BMC Musculoskelet Disord. 2016; 17:98. PMC: 4765070. DOI: 10.1186/s12891-016-0952-8. View

Yan S, Cui Y, Zhang X, Zhang G, Dong G, Feng Y . The incidence of extra-articular manifestations in southern Chinese patients with inflammatory joint diseases. Int J Rheum Dis. 2019; 22(9):1686-1694. DOI: 10.1111/1756-185X.13657. View

Ziegelasch M, Forslind K, Skogh T, Riklund K, Kastbom A, Berglin E . Decrease in bone mineral density during three months after diagnosis of early rheumatoid arthritis measured by digital X-ray radiogrammetry predicts radiographic joint damage after one year. Arthritis Res Ther. 2017; 19(1):195. PMC: 5581443. DOI: 10.1186/s13075-017-1403-0. View

Luque Ramos A, Redeker I, Hoffmann F, Callhoff J, Zink A, Albrecht K . Comorbidities in Patients with Rheumatoid Arthritis and Their Association with Patient-reported Outcomes: Results of Claims Data Linked to Questionnaire Survey. J Rheumatol. 2019; 46(6):564-571. DOI: 10.3899/jrheum.180668. View

10.

Lee J, Cho S, Han M, Lee S, Kim J, Ryu J . Validity and role of vertebral fracture assessment in detecting prevalent vertebral fracture in patients with rheumatoid arthritis. Joint Bone Spine. 2013; 81(2):149-53. DOI: 10.1016/j.jbspin.2013.07.003. View

11.

Mikuls T, Saag K, Curtis J, Bridges Jr S, Alarcon G, Westfall A . Prevalence of osteoporosis and osteopenia among African Americans with early rheumatoid arthritis: the impact of ethnic-specific normative data. J Natl Med Assoc. 2005; 97(8):1155-60. PMC: 1364462. View

12.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009; 151(4):264-9, W64. DOI: 10.7326/0003-4819-151-4-200908180-00135. View

13.

Piao H, Zhang K, Tang Z . Association between rheumatoid arthritics and osteoporosis among Chinese men, a community based study. Int J Clin Exp Med. 2015; 8(9):16592-8. PMC: 4659077. View

14.

Adami G, Saag K . Osteoporosis Pathophysiology, Epidemiology, and Screening in Rheumatoid Arthritis. Curr Rheumatol Rep. 2019; 21(7):34. DOI: 10.1007/s11926-019-0836-7. View

15.

Fauny M, Albuisson E, Bauer E, Perrier-Cornet J, Chary-Valckenaere I, Loeuille D . Study of vertebral fracture and Scanographic Bone Attenuation Coefficient in rheumatoid arthritis and ankylosing spondylitis vs. controls. Sci Rep. 2019; 9(1):13323. PMC: 6746735. DOI: 10.1038/s41598-019-49712-x. View

16.

Lee J, Suh Y, Koh J, Jung S, Lee J, Kwok S . The risk of osteoporotic fractures according to the FRAX model in Korean patients with rheumatoid arthritis. J Korean Med Sci. 2014; 29(8):1082-9. PMC: 4129199. DOI: 10.3346/jkms.2014.29.8.1082. View

17.

Gron K, Ornbjerg L, Hetland M, Aslam F, Khan N, Jacobs J . The association of fatigue, comorbidity burden, disease activity, disability and gross domestic product in patients with rheumatoid arthritis. Results from 34 countries participating in the Quest-RA program. Clin Exp Rheumatol. 2014; 32(6):869-77. View

18.

Chen B, Cheng G, Wang H, Feng Y . Increased risk of vertebral fracture in patients with rheumatoid arthritis: A meta-analysis. Medicine (Baltimore). 2016; 95(45):e5262. PMC: 5106053. DOI: 10.1097/MD.0000000000005262. View

19.

Panopoulos S, Tektonidou M, Drosos A, Liossis S, Dimitroulas T, Garyfallos A . Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: a comparative, multicenter, matched-cohort study. Arthritis Res Ther. 2018; 20(1):267. PMC: 6280404. DOI: 10.1186/s13075-018-1771-0. View

20.

Hauser B, Riches P, Wilson J, Horne A, Ralston S . Prevalence and clinical prediction of osteoporosis in a contemporary cohort of patients with rheumatoid arthritis. Rheumatology (Oxford). 2014; 53(10):1759-66. DOI: 10.1093/rheumatology/keu162. View